← Oncology Approval Tracker

FDA DECISION ·

Lapatinib (Tykerb first generic)

lapatinib · Natco Pharma

First generic approvalFirst genericBreast cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic Tykerb for use with capecitabine after specified prior therapy in HER2-positive advanced or metastatic breast cancer, or with letrozole in selected postmenopausal patients with hormone receptor-positive, HER2-positive metastatic disease.

LAMPGEN ANALYSIS

Why it matters

Added a generic source of the HER2-directed oral agent used in established combinations.

What research teams should watch

Check the intended partner drug and interaction and cardiac monitoring plans before substitution.

PRIMARY RECORDS

Sources